CareDx, Inc. — Regulatory Filings 2015

Dec 16, 2015

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): December 16, 2015

CAREDX, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-36536	94-3316839
(State or other jurisdiction of incorporation)	(Commission File No.)	(IRS Employer Identification Number)

3260 Bayshore Boulevard

Brisbane, California 94005

(Address of principal executive offices)

(415) 287-2300

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 7.01. Regulation FD Disclosure

On December 16, 2015, CareDx, Inc. (the “Company”) issued a press release announcing a tender offer to acquire the shares of Allenex AB. In the press release, the Company also announced that it would be holding a conference call on December 16, 2015 to discuss the tender offer. The full text of the press release is attached hereto as Exhibit 99.1 and the script for the conference call is attached hereto as Exhibit 99.2, and are incorporated herein by reference.

On December 16, 2015, the Company also issued a press release in Sweden announcing the recommended public offer to acquire the shares of Allenex AB. The full text of the press release is attached hereto as Exhibit 99.3 and is incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No.	Description
99.1	Press release issued by CareDx, Inc. dated December 16, 2015
99.2	Script for conference call on December 16, 2015
99.3	Press release issued by CareDx, Inc. dated December 16, 2015

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 16, 2015
By: /s/ Ken Ludlum
Ken Ludlum
Chief Financial Officer

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press release issued by CareDx, Inc. dated December 16, 2015
99.2	Script for conference call on December 16, 2015
99.3	Press release issued by CareDx, Inc. dated December 16, 2015